Latest in: FDA
Featured Image

Cracking the Code Of Biotech Valuation – ambiom on BeyondBiotech podcast

We spoke in detail about our activities at BeyondBiotech podcast, you can listen to the episode here: https://podcast.labiotech.eu/1995493/episodes/16219760-cracking-the-code-of-biotech-valuations
gravatar
 · 
December 10, 2024
Featured Image

FDA LDT Rule: 3 key changes for Laboratory Developed Tests (LDTs) in the US

Earlier this year the FDA has introduced significant regulatory changes for Laboratory Developed Tests (LDTs) to enhance their oversight and ensure higher standards of safety and effectiveness. These changes align LDTs with the regulatory …
gravatar
 · 
July 1, 2024
Featured Image

FDA has approved 55 new molecules in 2023

With a focus on addressing a wide spectrum of diseases and conditions, US witnessed the most novel drug approvals in 6 years. Here we provide an overview of the key highlights in treatments that …
gravatar
 · 
January 15, 2024

Impressum

ambiom s.r.o.
Karpatské námestie 7770/10A
831 06 Bratislava
IČO: 54219035

Contact

info@ambiom.com
+421 948 652 276

footer-FB
footer-Li
Footer-Insta

Newsletter

Back to top Arrow